To treat or not to treat: is the way forward clearer in low-risk prostate cancer?


  • Vincent J. Gnanapragasam

    1. Translational Prostate Cancer Group, Department of Oncology, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK
    2. Department of Urology, Addenbrookes Hospital, Cambridge, UK
    Search for more papers by this author

No abstract is available for this article.